Abderrazzak Merzouki
Chief Tech/Sci/R&D Officer bij SUNSHINE BIOPHARMA, INC.
Vermogen: 7 003 $ op 31-03-2024
Profiel
Abderrazzak Merzouki is currently the Chief Science Officer & Director at Sunshine Biopharma, Inc. since 2016.
He is also currently a Senior Scientist at Imperial College London since 2007.
Previously, he worked as the Director-Cell Engineering & Biotherapeutics at Hydrogen Future Corp.
Dr. Merzouki holds a graduate and doctorate degree from the University of Quebec and a doctorate degree from Institut Armand-Frappier.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-03-2024 | 116 720 ( 0.12% ) | 7 003 $ | 31-03-2024 |
Actieve functies van Abderrazzak Merzouki
| Bedrijven | Functie | Begin |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 25-01-2024 |
| Imperial College London | Corporate Officer/Principal | 04-02-2011 |
Eerdere bekende functies van Abderrazzak Merzouki
| Bedrijven | Functie | Einde |
|---|---|---|
| HYDROGEN FUTURE CORP | Corporate Officer/Principal | - |
Opleiding van Abderrazzak Merzouki
| University of Quebec | Doctorate Degree |
| Institut Armand-Frappier | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Hydrogen Future Corp.
 Hydrogen Future Corp. Agricultural Commodities/MillingProcess Industries Hydrogen Future Corp. operates as a holding company. The firm engages in the provision of contract research and laboratory services. It provides alternate energy generation products and services. The company was founded on June 21, 2006 and is headquartered in Houston, TX. | Process Industries |
